Literature DB >> 26034080

Long-term outcomes and complications of Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis following ocular surface burns: clinical experience in China.

Liqiang Wang1, Yifei Huang1, Gaiping Du1, Ying Dong2, Huiling Guo1, Dajiang Wang1, Jifeng Yu1, Qun Wang1, Bing Chen1, Lulu Hou1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the clinical outcomes of the implantation of MICOF keratoprosthesis (Kpro) in patients with alkaline, acid and thermal ocular burns.
METHODS: This is a retrospective, non-competitive, interventional case series. Ninety eyes of 90 patients with ocular burns underwent MICOF KPro surgery at the Chinese People's Liberation Army General Hospital between April 2000 and December 2012. Preoperative and postoperative findings were recorded. Retention of the prostheses and the treatment for postoperative complications were investigated.
RESULTS: The mean age of patients was 40.26±12.18 years (range: 8-64 years), and the mean duration after ocular trauma was 4.8±6.2 years (range: 1.5-12 years). The mean follow-up period was 58.22±36.28 months (range: 1-145 months). Eighty patients were followed for ≥1 year and 73 eyes (81.11%) achieved the best-corrected visual acuity of 20/200 or better and 39 eyes (43.33%) achieved best-corrected visual acuity of ≥20/40. The common complications were glaucoma, corneal melt and conjunctiva overgrowth, and the incidences of these complications were 59.99%, 40% and 31.11%, respectively. One patient experienced KPro extrusion, and two patients exhibited leakage from the area of the implant. Seven with endophthalmitis eyes had final visual acuities of light perception. There was no significant difference in the effectiveness of the implants among the different causes of injuries, including acid, alkali and thermal burns.
CONCLUSIONS: MICOF Kpro is an effective alternative for patients with ocular burn with corneal blindness. Glaucoma and endophthalmitis were identified as significant risk factors for visual loss. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2015        PMID: 26034080     DOI: 10.1136/bjophthalmol-2014-306115

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Subconjunctival Injection of Regulatory T Cells Potentiates Corneal Healing Via Orchestrating Inflammation and Tissue Repair After Acute Alkali Burn.

Authors:  Dan Yan; Fei Yu; Liangbo Chen; Qinke Yao; Chenxi Yan; Siyi Zhang; Nianxuan Wu; Danni Gong; Hao Sun; Yao Fu; Chunyi Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

2.  Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study.

Authors:  Zhao Li; Qun Wang; Shi-Feng Zhang; Yi-Fei Huang; Li-Qiang Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-29

3.  Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn.

Authors:  Yanqiao Huang; Lixia Lin; Yao Yang; Fang Duan; Miner Yuan; Bingsheng Lou; Xiaofeng Lin
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.